Kim HK - Search Results

1

Potentials and limitations of adenovirus-p53 gene therapy for brain tumors.

Hong YK, Joe YA, Yang YJ, Lee KS, Son BC, Jeun SS, Chung DS, Cho KK, Park CK, Kim MC, Kim HK, Yung WK, Kang JK. Hong YK, et al. Among authors: kim hk, kim mc. J Korean Med Sci. 2000 Jun;15(3):315-22. doi: 10.3346/jkms.2000.15.3.315. J Korean Med Sci. 2000. PMID: 10895975 Free PMC article.

2

The relationship between cisplatin-induced apoptosis and p53, bcl-2 and bax expression in human lung cancer cells.

Han JY, Chung YJ, Park SW, Kim JS, Rhyu MG, Kim HK, Lee KS. Han JY, et al. Among authors: kim hk, kim js. Korean J Intern Med. 1999 Jan;14(1):42-52. doi: 10.3904/kjim.1999.14.1.42. Korean J Intern Med. 1999. PMID: 10063313 Free PMC article.

3

Effects of buthionine sulfoximine treatment on cellular glutathione levels and cytotoxicities of cisplatin, carboplatin and radiation in human stomach and ovarian cancer cell lines.

Lee KS, Kim HK, Moon HS, Hong YS, Kang JH, Kim DJ, Park JG. Lee KS, et al. Among authors: kim hk, kim dj. Korean J Intern Med. 1992 Jul;7(2):111-7. doi: 10.3904/kjim.1992.7.2.111. Korean J Intern Med. 1992. PMID: 1306072 Free PMC article.

4

Nasal angiocentric lymphoma with hemophagocytic syndrome.

Han JY, Seo EJ, Kwon HJ, Min KO, Kim JS, Kang JH, Hong YS, Kim HK, Lee KS. Han JY, et al. Among authors: kim hk, kim js. Korean J Intern Med. 1999 Jul;14(2):41-6. doi: 10.3904/kjim.1999.14.2.41. Korean J Intern Med. 1999. PMID: 10461424 Free PMC article.

5

Disruption of interkringle disulfide bond of plasminogen kringle 1-3 changes the lysine binding capability of kringle 2, but not its antiangiogenic activity.

Lee H, Kim HK, Lee JH, You WK, Chung SI, Chang SI, Park MH, Hong YK, Joe YA. Lee H, et al. Among authors: kim hk. Arch Biochem Biophys. 2000 Mar 15;375(2):359-63. doi: 10.1006/abbi.1999.1675. Arch Biochem Biophys. 2000. PMID: 10700393

6

Quality of life (QOL) assessment of MIP (mitomycin, ifosfamide and cisplatin) chemotherapy in advanced non-small cell lung cancers (NSCLC).

Han JY, Kim HK, Choi BG, Moon H, Hong YS, Lee KS. Han JY, et al. Among authors: kim hk. Jpn J Clin Oncol. 1998 Dec;28(12):749-53. doi: 10.1093/jjco/28.12.749. Jpn J Clin Oncol. 1998. PMID: 9879293 Clinical Trial.

7

Purification and characterization of recombinant murine endostatin in E. coli.

You WK, So SH, Lee H, Park SY, Yoon MR, Chang SI, Kim HK, Joe YA, Hong YK, Chung SI. You WK, et al. Among authors: kim hk. Exp Mol Med. 1999 Dec 31;31(4):197-202. doi: 10.1038/emm.1999.32. Exp Mol Med. 1999. PMID: 10630374

8

A phase II study of a daily x4 schedule of vinorelbine plus cisplatin for advanced non-small cell lung cancer.

Han JY, Kim KW, Kim JA, Kang JH, Jin JY, Hong YS, Park SY, Song JS, Park JW, Kim HK, Lee KS, Choi BG. Han JY, et al. Among authors: kim hk, kim ja, kim kw. Jpn J Clin Oncol. 2000 Oct;30(10):435-9. doi: 10.1093/jjco/hyd118. Jpn J Clin Oncol. 2000. PMID: 11185889 Clinical Trial.

9

Evaluation of therapeutic regimens for the treatment of Helicobacter pylori infection.

Lee DH, Park HJ, Song SY, Lee SJ, Choi W, Lee YC, Chung JB, Kang JK, Park IS, Lee YH, Kim HK. Lee DH, et al. Among authors: kim hk. Yonsei Med J. 1996 Aug;37(4):270-7. doi: 10.3349/ymj.1996.37.4.270. Yonsei Med J. 1996. PMID: 8942297 Free article. Clinical Trial.

10

Overexpression of erbB-2 protein in gastric adenocarcinoma--a potential role in therapeutic response to adjuvant 5-FU-doxorubicin regimen.

Roh JK, Paik S, Chung HC, Yang W, Kim HK, Choi IJ, Kim J, Koh E, Lee KS, Min JS, et al. Roh JK, et al. Among authors: kim hk, kim j. Gan To Kagaku Ryoho. 1992 Jul;19(8 Suppl):1207-19. Gan To Kagaku Ryoho. 1992. PMID: 1355336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,973 results

Search Page

Filters